astrazeneca
-
Health
AstraZeneca Demonstrates Oncology Portfolio Dominance at European Society for Medical Oncology Congress in Madrid
The European Society for Medical Oncology (ESMO) congress in Madrid recently served as a definitive stage for AstraZeneca, underscoring the…
Read More » -
Health
AstraZeneca faces a significant setback as the breast cancer drug camizestrant fails to meet primary endpoints in a pivotal first-line clinical trial.
The pharmaceutical giant AstraZeneca confirmed on Friday that its novel oral endocrine therapy, camizestrant, failed to demonstrate a superior clinical…
Read More »
